sumitomo dainippon pharma co
(4506:Tokyo Stock Exchange)
Chiang J. Li M.D., FACP.
Executive Officer, Chief Executive Officer of Boston Biomedical, Inc, President of Boston Biomedical, Inc, Head of Global Oncology for Sumitomo Dainippon Pharma Group and Chief Medical Officer of Boston Biomedical, Inc,Sumitomo Dainippon Pharma Co., Ltd.
|Age||Total Calculated Compensation||This person is connected to 22 board members in 2 different organizations across 5 different industries.|
See Board Relationships
Dr. Chiang J. Li, M.D., FACP., serves as the President, Chief Executive Officer and Chief Medical Officer at Boston Biomedical, Inc. (BBI). Dr. Li serves as an Executive Officer and Head of Global Oncology of Sumitomo Dainippon Pharma Co., Ltd. He is the Founder of Cequent Pharmaceuticals, Inc. He serves as Head of Global Oncology at the DSP Group. Dr. Li served as the Chief Scientific Officer at Boston Biomedical, Inc. which he founded it in November 2006. He Founded ...
6-8 Doshomachi 2-chomePhone: 81 6 6203 5321
Osaka, -- 541-0045
Fax: 81 6 6202 6028
Board Members Memberships*
Founder, Chairman of the Scientific Advisory Board and Director
Harvard Medical School
Harvard-MIT Division of Health Sciences and Technology
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
|Brenton L. Saunders J.D.||Chairman, Chief Executive Officer and President|
|Shigetaka Komori||Chairman, Group Chief Executive Officer and Executive Officer|
FUJIFILM Holdings Corporation
|Christophe Weber||Chief Executive Officer, President and Representative Director|
Takeda Pharmaceutical Company Limited
|Dayanand Thandalam Sriram||Managing Director, Director, Member of Nomination & Remuneration Committee, Member of Risk Management & Corporate Governance Monitoring Committee, Member of Finance Committee and Member of Administrative Committee|
GlaxoSmithKline Consumer Nigeria Plc
|John Anthony Sedor||Chairman and Chief Executive Officer|
Pernix Therapeutics Holdings, Inc.
|--||Compensation as of Fiscal Year 2015.|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.